OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
2.785
+0.040 (1.46%)
At close: Aug 8, 2025, 4:00 PM
2.800
+0.015 (0.54%)
After-hours: Aug 8, 2025, 4:46 PM EDT
HashiCorp Revenue
OraSure Technologies had revenue of $31.24M in the quarter ending June 30, 2025, a decrease of -42.50%. This brings the company's revenue in the last twelve months to $138.53M, down -49.35% year-over-year. In the year 2024, OraSure Technologies had annual revenue of $185.83M, down -54.17%.
Revenue (ttm)
$138.53M
Revenue Growth
-49.35%
P/S Ratio
1.50
Revenue / Employee
$276,513
Employees
501
Market Cap
203.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 185.83M | -219.65M | -54.17% |
Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
OSUR News
- 3 days ago - OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - OraSure Appoints Anne Messing as Chief Commercial Officer - GlobeNewsWire
- 12 days ago - OraSure Technologies: An Asymmetric Bet - Seeking Alpha
- 19 days ago - OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th - GlobeNewsWire
- 26 days ago - OraSure Technologies received takeover bid from industry entrepreneur, sources say - Reuters
- 4 weeks ago - OraSure Launches Novel Blood Collection Device for Proteomic Research - GlobeNewsWire
- 2 months ago - Orasure Technologies: Multiple Shots To Deliver Value - Seeking Alpha
- 3 months ago - OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript - Seeking Alpha